Tumor necrosis factor a (TNFa) is a cytotoxic/cytostatic compound for a variety of human cancer cells. The p21 WAF1 protein is a cyclin-dependent kinase inhibitor (CDKI) that binds to cyclin/cyclin-dependent kinase (CDK) complexes and inhibits their kinase activities, thereby leading to cell cycle arrest. We found that the cytostatic eect of TNFa on the cervical cancer cell line, ME180, was concomitant with an arrest of these cells in the G0/G1 phase of the cell-cycle. This corresponded with an increase in both p21 WAF1 mRNA and protein levels which likely occurred via a p53-independent pathway since ME180 is infected with the human papilloma virus. To elucidate the role of p21 WAF1 in the TNFa-mediated growth and cell cycle arrest, we stably transformed ME180 cells with an antisense p21 WAF1 -expression vector. Two clones with reduced levels of p21 WAF1 both in their basal state as well as after their exposure to TNFa were selected. The growth of these cells was still inhibited by TNFa and they arrested in G0/G1 similar to wildtype or empty vector transfected cells. These results indicate that although p21 WAF1 expression increases dramatically with TNFa treatment, it may not play a critical role in the cytostatic eect of TNFa on ME180 cervical cancer cells.
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Keywords: ME180; p21 WAF1 ; TNFa; antisense Cyclin-dependent kinases (CDKs) and their respective cyclins act as positive regulators of progression through the cell cycle while cyclin-dependent kinase inhibitors (CDKIs) are important negative regulators (Sherr, 1994; Nurse, 1994; Morgan, 1995; Hirama and Koeer, 1995) . The CDKIs inhibit CDK activity by binding to CDKs or cyclin/CDK complexes, thus halting cell cycle progression (Hunter and Pines, 1994) . The p21 WAF1 (also known as CIP1, SDI1, or CAP20) gene encodes the ®rst described CDKI (Harper et al., 1993; El-Deiry et al., 1993; Noda et al., 1994; Gu et al., 1993) . In normal human diploid ®broblasts, p21 WAF1 forms part of a quaternary complex with cyclins, their respective CDKs and proliferating cell nuclear antigen (PCNA) Waga et al., 1994; . The p21 WAF1 protein inhibits the kinase activity of cyclin A/CDK2, cyclin B/CDC2, cyclin E/CDK2 and cyclin D/CDK4 complexes in vitro . Also, p21 WAF1 binds PCNA in the absence of cyclins and CDKs and inhibits PCNA-dependent DNA replication (Waga et al., 1994) .
Expression of p21
WAF1 mRNA is regulated during the cell-cycle . When normal human ®broblast cells were released from serum starvation, the p21 WAF1 mRNA reached maximal levels at the G0/G1 border, levels began to decrease at the G1/S boundary and fell to a minimum point during S phase . Overexpression leads to inhibition of cell growth by cell cycle arrest in the G1 phase in various cell types Harper et al., 1995) . This function of p21 WAF1 is important for p53-mediated arrest of cell growth (Ko and Prives, 1996) . The p53 protein leads to either growth arrest or apoptosis (Ko and Prives, 1996) . The ability of p53 to induce G1 arrest in response to DNA damage is mediated by upregulation of p21 WAF1 expression by p53 activation of p21 WAF1 transcription (El-Deiry et al., 1993; El-Deiry et al., 1994) . In support of this, p21 WAF1 7/7 cells are partially defective in cell cycle arrest in response to DNA damage by radiation (Deng et al., 1995; Brugarolas et al., 1995) . Also, the basal level of p21 WAF1 expression is much lower in p53-null cells compared to those with wildtype p53 Li et al., 1994; El-Deiry et al., 1994) .
Recently, studies have shown that p21 WAF1 expression can be induced via p53-independent pathways. For example, when the glioblastoma cell line, GM, which contains a mutated p53 gene, was cultured with dexamethasone, p21 WAF1 mRNA and protein expression increased (El-Deiry et al., 1993) . Likewise, cytokines such as either transforming growth factor-b or interferon-g, or irradiation induced p21 WAF1 in a p53-independent manner (Datto et al., 1995; Zhang et al., 1995; Akashi et al., 1995) . The induction of p21 WAF1 via these pathways correlated with G1 arrest. Also, induction of p21 WAF1 by p53-independent pathways was important in cellular dierentiation where growth arrest eventually occurred (Parker et al., 1995; Guo et al., 1995; Skapek et al., 1995; Missero et al., 1995; Schwaller et al., 1995) .
Tumor necrosis factor-a (TNFa) is a cytokine which is cytotoxic to many malignant cell lines, but the mechanism(s) of cytotoxicity is unclear (Rosenblum and Donato, 1989; Fiers, 1991) . The cytotoxic or apoptotic eects of TNFa on most cells are enhanced if RNA or protein synthesis is inhibited (Wong and Goeddel, 1988; Wong et al., 1989; Holtman et al., 1988) . This suggests that de novo mRNA or protein synthesis induces the expression of genes that protect against apoptotis (Wong and Goeddel, 1988; Wong et al., 1989; Holtman et al., 1988 ). TNFa appears to signal down several dierent pathways (Rosenblum and Donato, 1989; Fiers, 1991) . One initiates a death program, while another leads to a protective pathway that involves activation of NF-kB (Beg and Baltimore, 1996; and requires de novo mRNA and protein synthesis from currently unknown protective genes. Previously, we showed that TNFa exerted a growth inhibitory/cytostatic eect on various myeloid leukemia cell lines; and this was associated with an increase of p21 WAF1 mRNA and protein expression via a p53-independent pathway (Shiohara et al., 1996) . This suggested that p21 WAF1 may be one of the eector molecules of TNFa.
TNFa also exerts a cytostatic eect on the cervical cancer cell line ME180; however, in the presence of the protein synthesis inhibitor, cycloheximide (CHX), apoptosis occurs (Herzog and Collin, 1992; Manchester et al., 1993) . We investigated if the p21 WAF1 protein plays a role in mediating the cytostatic eect of TNFa on ME180 cells.
When cells cultured in medium containing 10% fetal calf serum, the number increased more than 90-fold by the 8th day compared to the beginning of culture ( WAF1 protein also increased in ME180 cells in a time-dependent manner ( Figure 2b ). The ME180 cell line is positive for human papilloma virus (HPV) (Srivastava et al., 1992) . The E6 virally encoded protein produced by HPV binds to the tumor suppressor p53 and inactivates it by degradation (Schener et al., 1990) ; therefore, p21 WAF1 induction probably occurs via a p53-independent pathway. Cell cycle analysis revealed that the percentage of cells in G0/G1 phase increased and that of S phase decreased by adding 10 3 IU/mL of TNFa for 48 h to the cultures (data not shown). During examination of the cells' morphology and cell cycle analysis, no increased apoptosis was observed (data not shown). These results indicate that exposure of ME180 cells to TNFa resulted in growth inhibition that was concomitant with induction of p21 WAF1 expression and cell cycle arrest in the G0/G1 phase.
We hypothesized that TNFa-induced expression of p21 WAF1 in ME180 cells may play a critical role in the TNFa-mediated growth inhibition. To test this, we transfected an antisense p21 WAF1 -expression construct into ME180 cells and selected several G418 resistant clones and characterized them for basal p21 WAF1 expression compared to an empty vector stable transformant. Two clones, AS-M and AS-F, were used in the following studies. Control cells (empty vector), AS-M and AS-F cells were cultured with 10 3 IU/mL of TNFa for 0 and 24 h. Western blot analysis showed that control ME180 cells expressed a low level of p21 WAF1 protein at 0 h, but the level markedly increased 24 h after the addition of TNFa (Figure 3 ). In contrast, basal expression of p21 WAF1 in AS-M and AS-F was much lower compared to the control cells at 0 h. TNFa upregulated p21 WAF1 protein expression in each cell line, but the induced level of protein was much lower in AS-M and AS-F than that of the control cells (Figure 3) . These results indicate that the antisense vector successfully decreased expression of both basal and induced levels of the p21 WAF1 protein.
Next, we analysed the eect of TNFa on the growth and cell cycle pro®le of these cells. We cultured control, AS-M, and AS-F cells without TNFa for 8 days and counted the cell number at the same time points in duplicate. As shown in Figure 4a , these three cell lines grew rapidly and became con¯uent by day 8. In contrast, when cultured with 10 3 IU/mL of TNFa, AS-M and AS-F, as well as the control cells, increased in cell number very slowly. TNFa inhibited the growth of these three cell lines equally. We analysed cell cycle status of the control and AS-M cells cultured with TNFa for 0 and 48 h in duplicate (Figure 4b ). Before adding TNFa, the mean percentage of control cells in the G0/G1, S, and G2/M phase were 62+3%, 28+3% and 10+1%, respectively. After adding TNFa, the percentage was 85+3%, 10+2% and 5+1%, respectively. For AS-M, the percentage of cells in the G0/G1, S, and G2/M phase before and after addition of TNFa was 65+4%, 24+2%, 11+1% and 82+3%, 13+2%, 5+1%, respectively. These results indicate that no dierences in the cell cycle status were observed between Figure 1 The eect of TNFa on the growth of ME180 cells. Recombinant humant TNFa, expressed in Escherichia coli, was purchased from Sigma Chemical Company (St Louis, MO) and was diluted in phosphate-buered saline (PBS) containing 1% bovine serum albumin (BSA). Human cervical cancer cell line, ME180 was obtained from the American Type Culture Collection (ATCC; Rockville, MD). The cell line was cultured in RPMI 1640 medium (GIBCO/BRL, Grand Island, NY), supplemented with 10% fetal bovine serum (GIBCO/BRL), 100 IU/ml of penicillin and 100 mg/ml of streptomycin (GIBCO/BRL) with or without 10 3 IU/ml of TNFa at 378C under air with 5% CO 2 . The cell numbers were counted on days 2, 4, 6 and 8. Each point represents the mean+s.d. (standard deviation) of duplicate cultures these two cell lines in the presence or absence of TNFa suggesting that p21 WAF1 probably is not involved in mediating the cytostatic eect of TNFa on ME180 cells.
Under normal tissue culture conditions (in the absence of mRNA or protein synthesis inhibitors), TNFa primarily exerts a cytostatic eect on ME180 cells (Herzog and Collin, 1992; Manchester et al., 1993) . This suggests that TNFa may activate expression of genes, such as p21 WAF1 , that lead to growth and cell cycle arrest. Our study demonstrated that the dramatic growth inhibition of wild-type ME180 cells in the presence of TNFa was correlated with an increase in p21 WAF1 mRNA and protein expression and cell cycle arrest. Even though the expression of p21 WAF1 was signi®cantly reduced in the p21 WAF1 -antisense expressing clones, the degree of growth inhibition and G0/G1 arrest was similar between control and antisense p21 3 IU/ml TNFa for 0, 12, and 24 h; total RNA was prepared by CsCl gradient ultracentrifugation of guanidine isothiocyanate-lysed cells as described previously (Shiohara et al., 1996) . Northern blot analysis were performed as described (Shiohara et al., 1996) . Twenty mg of RNA were used per lane. For the detection of p21 WAF1 mRNA, the cDNA excised from pCEP-WAF1 was used as a probe (Shiohara et al., 1996) . A b-actin probe was obtained as a 0.7 Kb EcoRI ± BamHI cDNA fragment from the plasmid pHFA-3'ut (Shiohara et al., 1996) . Blots were sequentially hybridized with the p21 WAF1 and the b-actin probes which were labeled by a random priming method (GIBCO/BRL). (b) p21 WAF1 protein expression is induced by TNFa. ME180 cells were cultured with 10 3 IU/ml TNFa for 0, 8, 16 and 24 h; cells were lysed and Western blot analysis was performed using the enhanced chemiluminescence system as described by the manufacturer (ECL, Amersham, Arlington Heights, IL) after incubation with monoclonal murine anti-human p21 WAF1 antibody (Oncogene Science, San Diego, CA). Fifteen mg of cell lysates were used per lane p21 1 2 3 4 5 6 Figure 3 Reduced p21 WAF1 protein expression in cells stably transformed with an antisense p21 WAF1 expression vector. The antisesnse expression vector was constructed by excising the p21 WAF1 cDNA (El-Deiry et al., 1993) from pCEP by NotI digestion and ligating into NotI cut pcDNAI (Invitrogen, San Diego, CA), an expression vector containing the immediate-early cytomegalovirus (CMV) promoter. The neomycin-resistant gene (neo) was inserted into pcDNAI. ME-180 cells were co-transfected with either the control vector (50 mg) or the antisense construct (50 mg) and the neo vector (5 mg) using the calcium phosphate precipitation method (Sambrook et al., 1989) . Twenty-four hours later, the cells were subcultured into medium containing G418 and resistant clones were isolated. ME180 cells stably transfected with control vector or antisense p21 WAF1 sequences (AS-M, AS-F) were cultured with or without 10 3 IU/ml TNFa for 24 h; cells were lysed and Western blot analysis was performed as described in the legend of Figure 2 . Lanes: 1, control vector, no TNFa; 2, control vector, plus TNFa. AS-M, no TNFa; 4, AS-M, plus TNFa; 5, AS-F, no TNFa; 6, AS-F, plus TNFa. Fifty mg/lane of protein were used 3 IUml of TNFa for 48 h. Cells exposed to TNFa were ®xed in methanol and the DNA content of the cells was detected by propidium iodide staining (Elstner et al., 1997) . The stained cells were analysed by FACScan (Becton-Dickinson, SanJose, CA) using the CELL FIT program (Becton-Dickinson). The data were analysed using the LYSIS II program (BectonDickinson). The mean percentages are from two independent experiments with duplicate cultures per experimental point ®ndings of the present study is that p21 WAF1 is not the only eector of TNFa. The transcriptional factor NFkB is a critical regulator of TNFa-inducible gene expression (Baeuerle and Henkel, 1994) . Genes regulated by nuclear NF-kB include cytokines, chemokines, and leukocyte adhesion molecules (Baeuerle and Henkel, 1994) . Recent studies showed that NF-kB activation plays an essential role in preventing TNFa-induced cell death (Beg and Baltimore, 1996; . It is possible that any of these NF-kB-induced genes could be involved in arresting cell growth. The binding of TNFa to the receptor can also activate TRADD which can mediate programmed cell death (Hsu et al., 1995) . Taken together, the NF-kB pathway may be more important in TNFa-induced cytostasis than is the induction of p21 WAF1 . A second possible explanation is that the reduced amount of p21 WAF1 expressed in antisense clone AS-M is still sucient for mediating the cytostatic eect of TNFa. Investigators have reported that growth arrest by prostaglandin A2 was diminished by introducing antisense p21 WAF1 in the RKO breast cancer cell line (Gorospe and Holbrook, 1996) . Another study showed that induction of antisense p21 WAF1 RNA removed the G0-to-G1 block in human diploid ®broblasts and resulted in entry into S phase and progression through the G2 to M phase of the cell cycle (Nakanishi et al., 1995) . Antisense-expressing cells in these reports also expressed low levels of p21 , increased in TGF-b-induced G1 arrest (Hunter and Pines, 1994; Guan et al., 1994) . We did not examine the eect of TNFa treatment on the INK4 family of CDKIs since retinoblastoma protein (pRb) function is abrogated by the E7 protein encoded by HPV (Slebos et al., 1994) . These CDKIs are likely not to function in cell cycle arrest at the G1-S phase in cells with inactivated pRb (Sherr and Roberts, 1995) . The level of p27 KIP1 protein in ME180 cells was unchanged after their exposure to TNFa (data not shown) suggesting that p27 KIP1 does not play a role in the TNFa-induced G1 arrest of these cells. A study on embryonic ®broblasts from p21 WAF1 -de®cient mice revealed that DNA damage-induced G1/S arrest is dependent only partially upon p21 WAF1 (Deng et al., 1995) . This indicated that a second, unknown p53-dependent checkpoint mechanism may exist (Deng et al., 1995) . Such a mechanism could involve GADD45, a p53-dependent, DNA damageinducible gene that arrests the cell cycle when overexpressed or the activation or inactivation of additional CDKIs or CDKs, respectively. Our results indicate that p21 WAF1 does not play an important role in the cytostatic eect induced by TNFa in ME180 cells and suggest that another pathway(s) regulated by TNFa is critical for this eect.
